Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections — Robert Snoeck (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections
Shared by
De Clercq Erik
KU Leuven
2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections
Article
2002
en
Authors
+12 more
RS
Robert Snoeck
GA
Graciela Andreï
BB
Bahram Bodaghi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1993
Strategies for the treatment of cytomegalovirus infections
Robert Snoeck
,
Johan Neyts
,
De Clercq Erik
Article
1997
Benzothiadiazine dioxide acyclonucleosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infections
Ana Martı́nez
,
Ana Esteban
,
De Clercq Erik
Article
1997
ChemInform Abstract: Benzothiadiazine Dioxide Acyclonucleosides as Lead Compounds for the Development of New Agents Against Human Cytomegalovirus and Varicella‐ Zoster Virus Infections.
Ana Martı́nez
,
Ana Esteban
,
De Clercq Erik
Article
1993
Strategies for the treatment and prevention of cytomegalovirus infections
Johan Neyts
,
De Clercq Erik
Article
2007
New Catalysts for Polymerizations of 1-Chloro-2-Phenylacetylenes
Jianzhao Liu
,
Jing Zhi Sun
,
Jacky W. Y. Lam
,
Wang Zhang Yuan
,
Haipeng Xu
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.